Effects of the kappa opioid receptor agonist nalfurafine on IFN-γ⁺CD4⁺... | Download Scientific Diagram
κ-opioid receptor - Wikipedia
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - Biological Psychiatry
Antagonists of the kappa opioid receptor - ScienceDirect
Characterization of Pyrrolidinyl-hexahydro-pyranopiperazines as a Novel Kappa Opioid Receptor Agonist Scaffold | ACS Chemical Neuroscience
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Figure 2 from Development of κ opioid receptor antagonists. | Semantic Scholar
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain - The Journal of Pain
Mu Agonist Opioids and Kappa Opioids | Download Table
Nalfurafine, a G-Protein–Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics | Hypertension
κ-opioid receptor - Wikipedia
Κ-opioid receptor - an overview | ScienceDirect Topics
Table II from Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. | Semantic Scholar
Opioids in cancer: The κ‑opioid receptor (Review)
Untangling the complexity of opioid receptor function | Neuropsychopharmacology